Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Re-Org Makes Chief Of Staff Liaison Between Centers, Commissioner

This article was originally published in The Tan Sheet

Executive Summary

The newly created FDA Office of the Chief of Staff will serve as the major point of contact for communication from FDA centers and offices to the commissioner, according to an Aug. 30 Federal Register notice

You may also be interested in...



FDA’s New Chief Of Staff Suggested Greater Authority On Nano-Supplements

FDA’s new chief of staff has recommended pre-market registration and testing of products with nanoparticles and post-market reviews of nano-engineered supplement ingredients.

FDA’s New Chief Of Staff Suggested Greater Authority On Nano-Supplements

FDA’s new chief of staff has recommended pre-market registration and testing of products with nanoparticles and post-market reviews of nano-engineered supplement ingredients.

Winckler leaves FDA

Susan Winckler, FDA chief of staff since January 2007, resigns, giving Commissioner Peggy Hamburg and the Obama administration further room to shape the agency. Winckler joined FDA as director for policy communications in September 2006, after serving as VP of policy and communications and staff counsel for the American Pharmacists Association. An August 2007 reorganization gave FDA's chief of staff a more central role and made deputy commissioners in the Office of the Commissioner report through Winckler (1"The Tan Sheet" Sept. 3, 2007)

Related Content

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel